Trial · NCT01727336
Participant flow36
How many started, completed or left each group, period by period.
1 to 20 of 36
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Part 1 Dalantercept Dose Escalation | STARTED | Part 1 Dalantercept 0.6 mg/kg | 6 | |
| Part 1 Dalantercept Dose Escalation | STARTED | Part 1 Dalantercept 0.9 mg/kg | 9 | |
| Part 1 Dalantercept Dose Escalation | STARTED | Part 1: Dalantercept 1.2 mg/kg | 14 | |
| Part 1 Dalantercept Dose Escalation | STARTED | Part 1: Dalantercept 1.5 mg/kg | 0 | |
| Part 1 Dalantercept Dose Escalation | STARTED | Part 2: Dalantercept 0.9 mg/kg Plus Axitinib | 0 | |
| Part 1 Dalantercept Dose Escalation | STARTED | Part 2: Placebo Plus Axitinib | 0 | |
| Part 1 Dalantercept Dose Escalation | COMPLETED | Part 1 Dalantercept 0.6 mg/kg | 3 | |
| Part 1 Dalantercept Dose Escalation | COMPLETED | Part 1 Dalantercept 0.9 mg/kg | 7 | |
| Part 1 Dalantercept Dose Escalation | COMPLETED | Part 1: Dalantercept 1.2 mg/kg | 6 | |
| Part 1 Dalantercept Dose Escalation | COMPLETED | Part 1: Dalantercept 1.5 mg/kg | 0 | |
| Part 1 Dalantercept Dose Escalation | COMPLETED | Part 2: Dalantercept 0.9 mg/kg Plus Axitinib | 0 | |
| Part 1 Dalantercept Dose Escalation | COMPLETED | Part 2: Placebo Plus Axitinib | 0 | |
| Part 1 Dalantercept Dose Escalation | NOT COMPLETED | Part 1 Dalantercept 0.6 mg/kg | 3 | |
| Part 1 Dalantercept Dose Escalation | NOT COMPLETED | Part 1 Dalantercept 0.9 mg/kg | 2 | |
| Part 1 Dalantercept Dose Escalation | NOT COMPLETED | Part 1: Dalantercept 1.2 mg/kg | 8 | |
| Part 1 Dalantercept Dose Escalation | NOT COMPLETED | Part 1: Dalantercept 1.5 mg/kg | 0 | |
| Part 1 Dalantercept Dose Escalation | NOT COMPLETED | Part 2: Dalantercept 0.9 mg/kg Plus Axitinib | 0 | |
| Part 1 Dalantercept Dose Escalation | NOT COMPLETED | Part 2: Placebo Plus Axitinib | 0 | |
| Part 2 Blinded | STARTED | Part 1 Dalantercept 0.6 mg/kg | 0 | |
| Part 2 Blinded | STARTED | Part 1 Dalantercept 0.9 mg/kg | 0 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01727336/flow